Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

COSCIENS Biopharma Inc T.AEZ


Primary Symbol: T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Comment by prophetoffactzon Jul 05, 2024 12:39pm
76 Views
Post# 36119933

RE:RE:A Big Thank you to Proph

RE:RE:A Big Thank you to Proph"What about the BG pill failure. Gagnon wasted millions of dollars on something that was shown by pthers to not work. The bozo went ahead with it anyway."

Was it a "failure"? PGX was developed in pursuit of the oat beta glucan pill. We wouldn't have had PGX. The oat beta glucan pill has been put on the backburner at the moment because AEZS has higher priorities. Gilles said he could go back to the pill and that the trial discovered data of interest such as a weight loss trend and concerning digestive health. AEZS is about to launch a chewy product with its oat beta glucan with health claims. Is it supported by what they found out with the oat beta glucan pill? AEZS is now entering the oat beta glucan food market. AEZS believes it has a superior oat beta glucan. The Angiogenesis Foundation has also been proving up oat beta glucan's wound healing capabilities. Could the pill be used one day for wound healing? Gilles said AEZS has the better oat beta glucan than in the functional drink that proved successful. Again, AEZS is so successful it has higher priorities than a drink.  
<< Previous
Bullboard Posts
Next >>